Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

7.9K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
7.9K
Glaucoma: Overview01:25

Glaucoma: Overview

1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

822
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
822
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Imaging Features of Herpetic Interstitial Keratitis by Anterior Segment Optical Coherence Tomography.

Cornea·2026
Same author

Brief Report: Clinical Features of Newly Diagnosed Cytomegalovirus Retinitis in South India.

Journal of acquired immune deficiency syndromes (1999)·2026
Same author

Characterizing Diagnostic Error in Referrals to an Academic Cornea and External Disease Practice.

American journal of ophthalmology·2025
Same author

Implications of Diagnostic Error in Ocular Surface Disease: The Role of Anchoring and Ambiguous Diagnostic Terminology.

JAMA ophthalmology·2024
Same author

Reply.

Ophthalmology·2024
Same author

Controllable Errors in the Management of Infectious Keratitis.

Cornea·2023

Related Experiment Video

Updated: Nov 17, 2025

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings
04:00

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings

Published on: August 2, 2024

2.7K

Neurotrophic Keratopathy: Ophthalmology's Diabetic Foot Problem.

Todd P Margolis1

  • 1John F. Hardesty, MD Department of Ophthalmology and Visual Sciences, Washington University in St. Louis, St. Louis, MO.

Eye & Contact Lens
|February 18, 2021
PubMed
Summary

Neurotrophic keratopathy requires a shift in perspective, viewing it as a chronic condition manageable through prevention, akin to diabetic foot issues. Early intervention and protective measures are crucial for healing the ocular surface.

More Related Videos

Author Spotlight: Advancing Corneal Innervation Research Through Innovative Models
06:10

Author Spotlight: Advancing Corneal Innervation Research Through Innovative Models

Published on: December 8, 2023

2.0K
Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
11:13

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells

Published on: April 7, 2016

9.4K

Related Experiment Videos

Last Updated: Nov 17, 2025

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings
04:00

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings

Published on: August 2, 2024

2.7K
Author Spotlight: Advancing Corneal Innervation Research Through Innovative Models
06:10

Author Spotlight: Advancing Corneal Innervation Research Through Innovative Models

Published on: December 8, 2023

2.0K
Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
11:13

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells

Published on: April 7, 2016

9.4K

Area of Science:

  • Ophthalmology
  • Corneal Disease
  • Ocular Surface Disease

Background:

  • Neurotrophic keratopathy is often mismanaged as an inflammatory condition.
  • Epitheliopathy results from denervation-induced dysregulation of ocular surface homeostasis.
  • Most affected eyes are not dry and do not require lubrication.

Purpose of the Study:

  • To reframe the understanding and management of neurotrophic keratopathy.
  • To emphasize prevention and protective strategies for the ocular surface.
  • To highlight the risks associated with topical agent use in this condition.

Main Methods:

  • Review of key concepts from the 2020 Harold A. Stein Lecture.
  • Analysis of the pathophysiology of neurotrophic epitheliopathy.
  • Discussion of traditional and alternative protective measures.

Main Results:

  • Neurotrophic keratopathy is a chronic condition best managed by prevention.
  • Inflammation is not the primary driver; dysregulated epithelial cell function is.
  • Topical agents can cause iatrogenic injury and delay healing.

Conclusions:

  • Ophthalmology should treat neurotrophic keratopathy like diabetic foot problems, focusing on prevention.
  • Minimizing topical agents, patient education, and protective eyewear are key.
  • Tarsorrhaphy remains a valuable method for protecting the neurotrophic cornea.